Madam Therapeutics

Uncategorized

PharmaCytics and Madam Therapeutics announce collaboration to develop a new class of oral anti-biotics

Amsterdam, November 5th. Today, the 2 Dutch biotech companies PharmaCytics and Madam Therapeutics have announced that they will develop a new class of antibiotics that do not need to be injected, but can be taken as a pill. Madam Therapeutics…

Remko van Leeuwen speaker at VIG Talk on the broken business model for antibiotics @ Dutch Association of Innovative Medicines

Remko van Leeuwen, founder and CEO of Madam Therapeutics, is the second speaker at the VIG Talk on October 29. VIG (“Vereniging Innovatieve Geneesmiddelen” in Dutch) is the Association of Innovative Medicines and represents the pharmaceutical sector in the Netherlands.…

European Commission publishes our screening-project for peptides to treat COVID-19 and bacterial infections for increased visibility to global investors

In a united spirit to COVID-19 response and to support the European recovery, the European Investment Project Portal (EIPP) and the Commission’s Research Directorate-General (RTD) have again put together their forces and acted as a team to acknowledge COVID-19 projects…

Pharma companies are creating a new $1 billion fund to acquire or invest in small antibiotic companies

Big Pharma exited from the antibiotics space one by one. And now they may be coming back together. Pfizer, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Bayer Pharmaceuticals, Merck KGaA and the American Merck — one of the last giants standing…

German scientist warns: ‘the danger of infectious diseases is completely underestimated ‘

German archeo-geneticist Johannes Krause has published a new book entitled “De reis van onze genen” (The journey of our genes). Krause conducts DNA research into infectious diseases that have plagued humanity for thousands of years. If we don’t take it…

Remko van Leeuwen interviewed for Dutch TV show “Eén Vandaag” on the problems of start-ups during corona times

Dutch TV news show “Eén Vandaag” viewed by around 1 million people today highlighted the financial challenges of Dutch start-ups during corona times. Remko van Leeuwen is one the CEOs that was interviewed for the program. During the interview (in…

Antibiotic resistance may rise after COVID-19, as doctors struggle to treat secondary infections. New antibiotics are urgently needed, but development is falling behind.

As the Covid-19 pandemic moves across the world, it may drag a second slow-motion pandemic behind it. Even though Covid-19 is a viral illness not affected by antibiotics, early data from hospitals shows that very high proportions of patients—more than…

Why Madam Therapeutics focuses on developing its SAAPs as treatment for both the Corona virus as well as superbugs during the COVID-19 crisis

We’re all focused on the coronavirus, but there’s another, major threat still lurking: superbugs. And the pandemic is a stark reminder of the need to be prepared for public health crises, particularly the growing danger of antibiotic-resistant bacteria, says Pew in…

New York Times: The Ganges River in India Brims With Dangerous Bacteria

The Ganges river in India is living proof that antibiotic-resistant bacteria are almost everywhere. The river offers powerful insight into the prevalence and spread of drug-resistant infections, one of the world’s most pressing public health problems. Its waters provide clues…